Electrocardiography

AI-assisted diagnosis of asymptomatic left ventricular dysfunction may detect disease early and thereby expedite treatment of low ejection fraction, according to data published in JACC: Advances.

Editor’s Note: This is part one of a three-part Healio Exclusive series on the development and use of AI to improve clinical outcomes in cardiovascular medicine and considerations for regulatory labeling and patient privacy .

BOSTON — Among patients with interstitial lung disease, 30% had pulmonary arterial hypertension and 20% had right ventricular hypertrophy, according to data presented at the CHEST Annual Meeting.

Polysomnography is the current gold standard in sleep testing, but a new method has achieved similar performance in sleep stage scoring via an electrocardiography-based deep learning neural network, according to a press release.

Several sports cardiologists shared their thoughts with Healio on whether ECG screening should be part of a pre-participation exam for young athletes.

Pre-participation screening, particularly whether an ECG should be included as part of a pre-participation exam for young athletes, is one of the most widely debated topics in sports cardiology.

AliveCor announced the FDA clearance and launch of its AI system designed to detect 35 cardiac conditions using a reduced leadset, in addition to its single-cable, AI-powered handheld ECG System.

A novel deep learning algorithm applied to a single preoperative ECG improved risk prediction for death after cardiac surgery and other inpatient procedures for a large cohort, researchers reported.

Patients hospitalized for a noncardiac reason with a first-time atrial fibrillation event in-hospital were more likely to have a recurrent event in the 12 months after discharge vs. matched controls with no prior AF, researchers reported.

Anumana announced it received FDA 510(k) clearance for its novel artificial intelligence-powered device to detect low left ventricular ejection fraction in patients at risk for HF.